ASPW yields 2000000.00% · PFE yields 6.13%● Live data
📍 ASPW pulled ahead of the other in Year 1
Combined, ASPW + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ASPW + PFE for your $10,000?
Arista Power, Inc. develops, supply, and integrates custom-designed power management systems, renewable energy storage systems, solar photovoltaic (PV) systems, and wind turbines in the United States. Its products include Power on Demand system, a patent-pending energy storage and management system that reduces customer's peak demand using inputs from multiple energy sources in conjunction with a custom-designed battery storage system and a proprietary smart monitoring technology. The company also offers Mobile Renewable Power Station, which integrates solar PV, wind turbines, fuel cells, and/or generators with an integrated onboard storage device for military and other applications. In addition, it designs, supplies, and installs solar PV panels either as a stand-alone system or integrated with its other products. The company was formerly known as WindTamer Corporation and changed its name to Arista Power, Inc. in May 2011. Arista Power, Inc. was incorporated in 2001 and is headquartered in Rochester, New York. On January 12, 2016, Arista Power, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Western District of New York.
Full ASPW Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.